Key result
FDG-PET imaging illustrates characteristic findings of pulmonary tumor thrombotic microangiopathy and can be helpful for its diagnosis.
Why the study?
Can FDG-PET help in the diagnosis of Pulmonary Tumor Thrombotic Microangiopathy?
Population
Patients with Pulmonary Tumor Thrombotic Microangiopathy (PTTM)
Design
Case_report
Authors
Loading...
May aid antemortem PTTM diagnosis in select cases; case reports leave open prospective validation.
Case Report
Can FDG-PET help in the diagnosis of Pulmonary Tumor Thrombotic Microangiopathy?
FDG-PET may be a useful imaging modality for the difficult antemortem diagnosis of pulmonary tumor thrombotic microangiopathy.
Tashima et al. (2009) conducted a case report in Pulmonary tumor thrombotic microangiopathy (PTTM). 2-(F-18)-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) was evaluated. FDG-PET imaging illustrates characteristic findings of pulmonary tumor thrombotic microangiopathy and can be helpful for its diagnosis.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: